Astellas Pharma Inc. Share Price OTC Markets
Stocks
ALPMY
US04623U1025
Pharmaceuticals
OTC Markets Traded|
Delayed
OTC Markets
16:41:01 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 15.05 USD | +0.60% |
|
+2.24% | +13.24% |
| 08-17 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,280B 26.96B 23.08B 21.54B 19.76B 37.13B 2,580B 37.86B 255B 99.59B 1,293B 101B 99.02B | P/E 2027 * |
11.6x | P/E 2028 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4,238B 26.7B 22.86B 21.33B 19.57B 36.77B 2,554B 37.49B 253B 98.62B 1,280B 100B 98.05B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.8x |
| Free-Float |
98.88% | Yield 2027 * |
3.36% | Yield 2028 * | 3.47% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.60% | ||
| 1 week | +2.24% | ||
| Current month | +9.61% | ||
| 1 month | +10.66% | ||
| 3 months | +4.30% | ||
| 6 months | -5.70% | ||
| Current year | +13.24% |
| 1 week | 14.26 |  | 15.18 |
| 1 month | 13.04 | | 15.18 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.03 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.60% | +2.24% | - | - | 27.31B | |
| +1.70% | +7.49% | +78.71% | +130.62% | 1,109B | |
| +1.46% | +4.28% | +51.73% | +62.23% | 644B | |
| +1.47% | +6.70% | +27.05% | +77.26% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | |
| +1.84% | +6.05% | +48.90% | +68.93% | 234B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | |
| +2.78% | +6.83% | +27.27% | +94.64% | 178B | |
| Average | +1.46% | +3.00% | +31.86% | +53.93% | 417.9B | |
| Weighted average by Cap. | +1.52% | +3.26% | +45.17% | +73.65% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,315B 14.59B 12.49B 11.65B 10.69B 20.09B 1,396B 20.48B 138B 53.88B 699B 54.76B 53.57B | 2,137B 13.46B 11.52B 10.75B 9.86B 18.54B 1,288B 18.9B 128B 49.72B 645B 50.53B 49.43B |
| Net income | 356B 2.24B 1.92B 1.79B 1.64B 3.09B 214B 3.15B 21.24B 8.28B 107B 8.42B 8.23B | 333B 2.09B 1.79B 1.67B 1.54B 2.89B 200B 2.94B 19.85B 7.74B 100B 7.87B 7.69B |
| Net Debt | -41.87B -264M -226M -211M -193M -363M -25.24B -370M -2.5B -974M -12.65B -990M -969M | -439B -2.77B -2.37B -2.21B -2.03B -3.81B -265B -3.88B -26.21B -10.22B -133B -10.38B -10.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | US$15.05 | +0.60% | 57,751 |
| 20/08/26 | US$14.96 | -0.99% | 185,962 |
| 19/08/26 | US$15.11 | +4.79% | 178,364 |
| 18/08/26 | US$14.42 | +0.63% | 83,689 |
| 17/08/26 | US$14.33 | -2.65% | 92,840 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
